Is EVMN or EVO more undervalued in 2026?

CirclFi compares Evommune, Inc. (EVMN) and Evotec SE (EVO) using 13 institutional-grade valuation models. EVMN has a Quality of Company score of 6.0/10 while EVO scores 6.2/10.

Which is a better buy — EVMN or EVO?

Compare intrinsic values from 13 independent models against current market prices. CirclFi also calculates Value Trap scores. This is not financial advice — conduct your own analysis.

How do EVMN and EVO valuations compare?

EVMN at $23.23 and EVO at $3.07 are compared across Bayesian DCF, EPV, EROIC Spread, First Chicago, Markov DDM, and 8 additional models.

EVMN vs EVO Valuation Comparison 2026 — Intrinsic Value Analysis

EVMN

Pharmaceutical Preparations

Evommune, Inc.

Quality

6.0

out of 10

Value Trap

—

Price

$23.23

Last close

Models

9/13

Active

EVO

Pharmaceutical Preparations

Evotec SE

Quality

6.2

out of 10

Value Trap

SAFE

Price

$3.07

Last close

Models

10/13

Active

Model-by-Model Comparison

Model	Type	EVMN Fair Value	EVMN Upside	EVO Fair Value	EVO Upside
Bayesian DCF	Intrinsic	$3.72	-84.0%	$0.22	-92.8%
EROIC Spread	Intrinsic	$•••.••	••.•%	$•••.••	••.•%
First Chicago	Scenario	$•••.••	••.•%	$•••.••	••.•%
ML-RIV	Intrinsic	$0.59	-97.6%	$1.13	-63.1%
Dynamic NAV	Asset-Based	$2.55	-89.6%	$1.58	-48.5%
PWERM	Option-Based	$•••.••	••.•%	$•••.••	••.•%
Regime Cross-Sectional	Relative	$•••.••	••.•%	$•••.••	••.•%
Sentiment SOTP	Hybrid	$•••.••	••.•%	$•••.••	••.•%
CUCE Ensemble	Ensemble	$•••.••	••.•%	$•••.••	••.•%
FTNN Topology	Relative	$•••.••	••.•%	$•••.••	••.•%

🔒

Unlock Full 13-Model Comparison

Access all valuation models for EVMN vs EVO — including EROIC Spread, First Chicago, Markov DDM, PWERM, and 7 more.

Access Full Analysis — From $27/mo →

EVMN vs EVO — Which Stock Is More Undervalued?

EVO scores higher with a 6.2/10 quality rating vs EVMN's 6.0/10. Both stocks are analyzed daily using SEC EDGAR filings across 13 independent models.

Comparing Evommune, Inc. (EVMN) and Evotec SE (EVO) across 13 institutional-grade valuation models reveals how each company's intrinsic value stacks up against its market price. CirclFi's engine processes SEC EDGAR 10-K and 10-Q filings, FRED macroeconomic data, and GDELT news sentiment to generate independent fair value estimates daily.

EVMN currently trades at $23.23 with a QOC of 6.0/10, while EVO trades at $3.07 with a QOC of 6.2/10.

Both companies are analyzed with models spanning intrinsic (Bayesian DCF, EPV), scenario-based (First Chicago), regime-switching (Markov DDM, RCMH-DCF), machine learning (ML-RIV, FTNN Topology), and ensemble methods (CUCE).